Abstract
Concentrations of 5-fluorouracil (FU) were measured in the plasma of patients receiving i.v. infusions of the drug for 5 days as treatment for adenocarcinoma of the gastrointestinal tract. Concentrations of FU varied widely in many patients. Concentration of drug X time of infusion (C X t values) were calculated. Patients showing a partial response or stabilization of disease had significantly higher C X t values than non-responders. Methyl CCNU did not affect the C X t values of FU. Determination of the plasma concentration of FU would allow the dose of the drug to be adjusted to maintain high concentrations of FU in the plasma. Our data suggest that such high concentrations would increase the response rate in this disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CLARKSON B., O'CONNOR A., WINSTON L., HUTCHISON D. THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN. Clin Pharmacol Ther. 1964 Sep-Oct;5:581–610. doi: 10.1002/cpt196455581. [DOI] [PubMed] [Google Scholar]
- Cohen J. L., Irwin L. E., Marshall G. J., Darvey H., Bateman J. R. Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893). Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):723–731. [PubMed] [Google Scholar]
- Hahn R. G., Moertel C. G., Schutt A. J., Bruckner H. W. A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinoma. Cancer. 1975 Apr;35(4):1031–1035. doi: 10.1002/1097-0142(197504)35:4<1031::aid-cncr2820350403>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
- Hillcoat B. L., Banerjee M., McCulloch P. B., Williams C. K. Prediction of marrow toxicity in patients treated by intravenous infusion of 5 fluorouracil. Eur J Cancer. 1977 Jan;13(1):81–87. doi: 10.1016/0014-2964(77)90233-x. [DOI] [PubMed] [Google Scholar]
- Hillcoat B. L., Kawai M., McCulloch P. B., Rosenfeld J., Williams C. K. A sensitive assay of 5-fluorouracil in plasma by gas chromatography-mass spectrometry. Br J Clin Pharmacol. 1976 Feb;3(1):135–143. doi: 10.1111/j.1365-2125.1976.tb00580.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moertel C. G., Schutt A. J., Hahn R. G., Reitemeier R. J. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine. J Natl Cancer Inst. 1975 Jan;54(1):69–71. doi: 10.1093/jnci/54.1.69. [DOI] [PubMed] [Google Scholar]
- Seifert P., Baker L. H., Reed M. L., Vaitkevicius V. K. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer. 1975 Jul;36(1):123–128. doi: 10.1002/1097-0142(197507)36:1<123::aid-cncr2820360108>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
- Woolley P. V., 3rd, Macdonald J. S., Schein P. S. Chemotherapy of colorectal carcinoma. Semin Oncol. 1976 Dec;3(4):415–420. [PubMed] [Google Scholar]